Educational Video Series


Michael Girschikofsky, MD

Michael Girschikofsky

Michael Girschikofsky, MD, is the Deputy Head of the Division Medicine I (Hematology and Stem Cell Transplantation, Hemostasis and Medical Oncology) and Deputy Medical Director at the Elisabethinen Hospital Linz, Austria.

Dr. Girschikofsky graduated from the Leopold-Franzens University at Innsbruck, Austria in 1990 and completed his internal medicine residency and hematology and oncology fellowship at Elisabethinen Hospital Linz in 2000.

Dr. Girschikofsky`s research interests focus on the biology and treatment of adult acute leukemias, prevention and therapy of fungal infections, and the biology and clinical management of Langerhans cell histiocytosis and other histiocytic disorders. He is a member of the scientific board of the Austrian Society of Hematology and Medical Oncology and member of the AGMT-study group board.

For many years Dr. Girschikofsky has worked on the Austrian Langerhans Cell Histiocytosis Registry and consults worldwide physicians of patients with histiocytic disorders. He is a member of the scientific board of the German Patient Association HistiozytoseHilfe e.V., a Project Partner of Euro Histio Net, and since 2012 member of the LCH Steering Committee and chair of the Adult Histiocytosis Study Group of the Histiocyte Society. In 2013 he published in cooperation with other recognized experts the first available recommendations for the management of adult patients with Langerhans Cell Histiocytosis.

 

View Dr. Girschikofsky's video: LCH in Adults Overview
Return to Educational Video Series page

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!